Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Dr Martens aims to achieve £25m in savings as profits decline | Business News

Reading Time: < 1 minute

Dr Martens, the iconic British footwear brand, has reported a sharp decline in profits for the second consecutive year, citing a challenging business environment. The company revealed that global pre-tax profits for the 12 months ending in March plummeted by almost 43% to £97 million, with revenue also dropping by 12% to £877 million.

The primary reason for the disappointing performance was attributed to the US market, where weak consumer demand and a 17% decrease in boot sales were observed. Kenny Wilson, the outgoing chief executive, acknowledged the results as expected and emphasized the need to drive demand in the US to achieve growth.

To address the situation, Dr Martens announced plans to implement cost-saving measures of up to £25 million through organizational efficiency and operational streamlining. Additionally, the company highlighted the positive response to its new shoe repair service in the UK, which has been described as “very encouraging.” The service is set to expand to other key markets in the future.

Despite the challenges faced in the US, Dr Martens reported robust performance in Europe, the Middle East, Africa, and the Asia-Pacific region. The company remains optimistic about its future prospects and is confident that the strategic actions being taken will position it for success in the years ahead.

Founded in 1960 in Northamptonshire, Dr Martens made its London stock market debut in 2021. However, its share price has since declined by approximately 80% since its listing on the FTSE 250 index. The company’s resilience and adaptability will be crucial as it navigates through the evolving business landscape.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money